| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/20/1997 | CN1157567A Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
| 08/20/1997 | CN1157560A Implanted device containing tumor cells for treatment of cancer |
| 08/20/1997 | CN1157140A Capsule using clam extract as main medicinal component and producing method thereof |
| 08/20/1997 | CN1035675C Novel process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives |
| 08/19/1997 | US5659083 Process of preparing 2,2'-(1-methyl-1,2-ethanediylidene) bis[hydrazinecarboximidamide] |
| 08/19/1997 | US5659061 Antitumor agents, enzyme inhibitors |
| 08/19/1997 | US5659027 Boronated compounds |
| 08/19/1997 | US5659013 Vascular permeability factor targeted compounds |
| 08/19/1997 | US5658949 Inhibition of tumor necrosis factor by retinoic acid |
| 08/19/1997 | US5658947 Topically applying betulinic acid or derivative |
| 08/19/1997 | US5658945 Anticancer agent; aids therapy; controlling infections |
| 08/19/1997 | US5658940 Inhibitors of tumor necrosis factor |
| 08/19/1997 | US5658935 Useful as inhibitors of thrombocyte aggregation, the metastasis of carcinoma cells and the binding of osteoclasts on bone surfaces |
| 08/19/1997 | US5658898 Intravenous solutions for a derivative of staurosporine |
| 08/19/1997 | US5658879 Enhancement of antitumor therapy with hemoglobin-based conjugates |
| 08/19/1997 | US5658803 For diagnosis, prophylaxis, treatment of bacterial infections |
| 08/19/1997 | US5658774 Inhibiting growth of tumor cells expressing oncogenes by introducing in vitro dna sequence encoding interferon regulatory factor, expressing said sequence |
| 08/19/1997 | US5658568 Cytotoxic drug therapy |
| 08/19/1997 | CA2020633C Mutant of pseudomonas, a strain yzh, and a process for producing 851 yzh nutrient solution by application of the strain |
| 08/19/1997 | CA2007353C Superficial therapeutic system comprising an antineoplastic active substance, particularly 5-fluorouracil |
| 08/14/1997 | WO1997029196A1 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy |
| 08/14/1997 | WO1997029195A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 08/14/1997 | WO1997029183A2 Methods and compositions for transforming dendritic cells and activating t cells |
| 08/14/1997 | WO1997029181A1 A method for selectively purging cd77+ cells from bone marrow |
| 08/14/1997 | WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a) |
| 08/14/1997 | WO1997029119A1 Fhit proteins and nucleic acids and methods based thereon |
| 08/14/1997 | WO1997028816A1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| 08/14/1997 | WO1997028808A1 Methods of inhibiting leaderless protein export using cardiac glycosides or aglycones therefrom and derivatives |
| 08/14/1997 | DE19605105A1 Neue Sonde zur Früherkennung von epithelialen Dysplasien des mehrschichtigen Plattenepithels sowie zur Tumordiagnostik und Tumortherapie von Plattenepithelkarzinomen New probe for early detection of epithelial dysplasia of the stratified squamous epithelium as well as for tumor diagnosis and tumor therapy of squamous cell carcinoma |
| 08/14/1997 | CA2733866A1 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 08/14/1997 | CA2539273A1 A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 08/14/1997 | CA2245170A1 Methods and compositions for transforming dendritic cells and activating t cells |
| 08/14/1997 | CA2242245A1 Methods of inhibiting leaderless protein export using cardiac glycosides or aglycones therefrom and derivatives |
| 08/13/1997 | EP0788540A1 Human abh |
| 08/13/1997 | EP0788515A1 Non-antigenic branched polymer conjugates |
| 08/13/1997 | EP0788509A1 Therapeutic peptide derivatives |
| 08/13/1997 | EP0788507A1 L-pyranosyl nucleosides |
| 08/13/1997 | EP0788506A2 L-ribofuranosyl nucleosides |
| 08/13/1997 | EP0788495A2 L-erythrosyl nucleosides |
| 08/13/1997 | EP0788493A1 Taxoid derivatives, their preparation and their use as antitumor agents |
| 08/13/1997 | EP0788492A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 08/13/1997 | EP0788388A1 Device for aerosolized delivery of peptide drugs |
| 08/13/1997 | EP0788374A2 Cell-specific gene delivery vehicles |
| 08/13/1997 | EP0788373A1 Novel complexes and their compositions |
| 08/13/1997 | EP0788366A1 Use of 2'-substituted oligonucleotides to down-regulating gene expression |
| 08/13/1997 | EP0788364A1 Treatment of urogenital cancer with boron neutron capture therapy |
| 08/13/1997 | EP0788361A1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 08/13/1997 | EP0788360A1 Boronic ester and acid compounds, synthesis and uses |
| 08/13/1997 | EP0788356A2 Method and compositions for inhibiting protein kinases |
| 08/13/1997 | EP0788307A1 Oligonucleotide modulation of multidrug resistance-associated protein |
| 08/13/1997 | EP0689430B1 Superparamagnetic particles, process for producing the same and their use |
| 08/13/1997 | EP0638064B1 Substituted 1,1,2-triphenylbutenes and their use in the treatment and diagnosis of cancer |
| 08/13/1997 | EP0558663B1 Drug delivery porphyrin compositions and methods |
| 08/13/1997 | EP0458937B1 Variants of pai-2 |
| 08/13/1997 | CN1157024A Pumping device |
| 08/13/1997 | CN1156995A Vitronectin receptor antagonists |
| 08/13/1997 | CN1156965A Cytokine regulatory agents and method of use in pathologies and conditions associated with altered cytokine levels |
| 08/13/1997 | CN1156964A Novel Peptides |
| 08/13/1997 | CN1035617C N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines |
| 08/13/1997 | CN1035616C 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 08/13/1997 | CA2197265A1 Target cell-specific vectors for inserting genes into cells, pharmaceuticals comprising such vectors and their use |
| 08/12/1997 | US5656736 Antibacterial, antitumor agents |
| 08/12/1997 | US5656726 Antiinflammatory agents, antiarthritic agents |
| 08/12/1997 | US5656654 Tyrosine kinase inhibitors |
| 08/12/1997 | US5656651 Androgenic directed compositions |
| 08/12/1997 | US5656615 Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals |
| 08/12/1997 | US5656612 Antisense oligonucleotide modulation of raf gene expression |
| 08/12/1997 | US5656611 Modified polynucleotide and copolymer having polyether segments and polycation segments; stabilizing polynucleic acids and increasing ability to cross cell membranes |
| 08/12/1997 | US5656595 Culture product; exchange with protin p21-guanosine diphosphate complex |
| 08/12/1997 | US5656484 Genetic engineering |
| 08/12/1997 | US5656465 Methods of in vivo gene delivery |
| 08/12/1997 | US5656444 Forming monoclonal antibody-oncofetal protein complex |
| 08/07/1997 | WO1997028280A1 Diagnostic method and apparatus |
| 08/07/1997 | WO1997028251A1 Combined radiotherapy and immunotherapy to treat cancer |
| 08/07/1997 | WO1997028190A1 Cytokine antagonists and agonists |
| 08/07/1997 | WO1997028186A1 PURIFIED SR-p70 PROTEIN |
| 08/07/1997 | WO1997028178A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | WO1997028175A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 08/07/1997 | WO1997028164A1 9,10 disubstituted camptothecin derivatives with antitumor activity |
| 08/07/1997 | WO1997028156A1 Taxane derivatives having a pyridyl substituted c13 side chain, their preparation and their use as anti-tumor agents |
| 08/07/1997 | WO1997028141A1 Novel aromatic piperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions, and use thereof as drugs |
| 08/07/1997 | WO1997028140A1 NOVEL PIPERIDINES DERIVED FROM 1-/(PIPERAZIN-1-YL)ARYL(OXY/AMINO)CARBONYL/-4-ARYL-PIPERIDINE AS SELECTIVE 5-HT1Db RECEPTOR ANTAGONISTS |
| 08/07/1997 | WO1997028123A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 08/07/1997 | WO1997027858A1 Combination therapy method for treating cancer using edatrexate and a taxane derivative, e.g. paclitaxel |
| 08/07/1997 | WO1997027848A1 SENSITIZATION OF HER2/neu OVER-EXPRESSING CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS |
| 08/07/1997 | DE19605024A1 Neue selektive Taxane, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New selective taxanes, processes for their preparation and their pharmaceutical use |
| 08/07/1997 | CA2630098A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | CA2246419A1 Combination therapy method for treating cancer using edatrexate and a taxane derivative, e.g. paclitaxel |
| 08/07/1997 | CA2245165A1 Sensitization of her2/neu over-expressing cancer cells to chemotherapeutic drugs |
| 08/07/1997 | CA2244940A1 Novel piperidines derived from 1-/(piperazin-1-yl)aryl(oxy/amino)carbonyl/-4-aryl-piperidine as selective 5-ht1db receptor antagonists |
| 08/07/1997 | CA2244746A1 Taxane derivatives having a pyridyl substituted c13 side chain, their preparation and their use as anti-tumor agents |
| 08/07/1997 | CA2243191A1 Diagnostic method and apparatus |
| 08/06/1997 | EP0787739A1 Anti-adhesive piperidine and pyrollidine -carboxylic acids |
| 08/06/1997 | EP0787733A2 Novel bioactive substance K93-0711 I-1 and I-2, and process for production thereof |
| 08/06/1997 | EP0787726A1 Novel compound, process for producing the same, and antitumor agent |
| 08/06/1997 | EP0787722A1 Substituted quinazoline derivatives |
| 08/06/1997 | EP0787492A1 Use of nitroxides and oxazolidines for protection against ionising radiation and oxidative stress |
| 08/06/1997 | EP0787197A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 08/06/1997 | EP0787148A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/06/1997 | EP0787138A1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |